Determination of ED95 of remimazolam to achieve loss of consciousness during anesthesia induction in obesity patients

Determination of ED95 of remimazolam to achieve loss of consciousness during anesthesia induction in obesity patients - RMMINDUCTION1

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000055545

Enrollment

Registered

2024-10-25

Start date

2024-01-25

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obese patient, ASA class I,II

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: among obese patients, ASA I,II over 19 years old, body mass index over 30kg/m2

Exclusion criteria

Exclusion criteria: Patients allergic to benzodiazepines Patients who regularly use sleeping pills, benzodiazepines, opioids, or alcohol Patients with communication difficulties (ex. hearing impairment, dementia, etc.)

Design outcomes

Primary

Measure	Time frame
ED95 of remimazolam	—

Countries

Asia(except Japan)

Contacts

Public ContactJiyoun Lee

Seoul national university Bundang hospital Anesthesiology and Pain medicine

heykiki1@hanmail.net+82317877499

Outcome results